AVITA Medical, Inc. (RCEL) Q4 2025 Earnings Call Transcript

Operator

Good day, and thank you for standing by. Welcome to the AVITA Medical, Inc. Fourth Quarter and Full Year 2025 Earnings Conference Call. [Operator Instructions]. Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to your first speaker today, Ben Atkins. Please go ahead.

Ben Atkins
Vice President of Investor Relations & Corporate Communications

Thank you, operator. Welcome to AVITA Medical’s Fourth Quarter and Full Year 2025 Earnings Call. Joining me on today’s call are Cary Vance, Interim Chief Executive Officer; and David O’Toole, Chief Financial Officer.

Today’s earnings release and presentation are available on our website at www.avitamedical.com under the Investor Relations section.

Before we begin, I would like to remind you that this call includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results to differ materially from any expectations expressed or implied by the forward-looking statements.

Please review our most recent filings with the SEC for comprehensive descriptions of the risk factors. Any forward-looking statements provided during this call are based on management’s expectations as of today.

I will now turn the call over to Cary.

Cary Vance
Independent Non-Executive Chairman & Interim CEO

Good afternoon in the U.S., and good morning in Australia. Thank you for joining us today. Before we get into the